X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

ACHEMA 2022 addresses the industry’s key issues digitalisation and sustainability

Content Team by Content Team
14th June 2022
in Manufacturing, Middle East and South Asia, Press Statements
ACHEMA 2022 addresses the industry's key issues digitalisation and sustainability

In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political situation also poses massive challenges for the process industry. Which technologies can be used to achieve defossilisation? How to secure and enhance regional and global supply chain networks? And what hurdles must be overcome in the digitalisation of the industry? ACHEMA 2022 offers answers and solutions to these and many more questions.

Europe aims to become climate-neutral by 2050. In line with this target, the chemical industry is working on technologies to achieve this goal. What are the opportunities, challenges, and obstructions? How do we shape the necessary political framework and incentives? Which financial instruments are required? These questions will be addressed at the opening event of ACHEMA entitled “Climate-Neutral Chemical Industry” on 22 August 2022 from 5 pm at the end of the first exhibition day.

After the welcome address and opening of ACHEMA by Klaus Schäfer, Chief Technology Officer of Covestro AG and Chairman of DECHEMA e.V., Martin Brudermüller, President of CEFIC – The European Chemical Industry Council and CEO of BASF SE, will present the perspective of the European chemical industry in his keynote speech. Open questions will be discussed in the subsequent panel discussion, with Martijn Smit, Business Development Director of Northern Lights, and Ernst Rauch, Chief Climate and Geo Scientist of Munich Re, joining the panel.

Green Innovation Zone shows solutions for a more sustainable future

The challenges and solutions for a more sustainable future are also addressed by the “Green Innovation Zone”: This special area brings together pioneers, experts and solution providers from industry, politics, and science with decisionmakers and users. The Green Innovation Zone highlights green innovations and the challenges faced by the process industry on its way to climate-neutral production. Five areas in particular will be in the spotlight at ACHEMA:  climate-neutral production, circular economy, industrial water, sustainable chemistry, bio-based economy.

“The process industry will have to electrify its facilities across the board and use hydrogen as an energy source in the medium term if it wants to live up to its responsibility for sustainable value creation,” adds Frank Jenner, Global Chemicals & Advanced Materials Industry Leader at EY, the main green innovation partner of ACHEMA 2022. “The industry is already going to great lengths and it’s a huge challenge, but it can be done.”

„With this year’s ACHEMA – perhaps more than ever – we are sending out a signal that technological cooperation across industry boundaries, but also across national borders, is indispensable for solving the significant crises of our time“, says Thomas Scheuring, CEO of DECHEMA Ausstellungs-GmbH. Björn Mathes, Member of the Board of DECHEMA Ausstellungs-GmbH, adds: „As an industry platform, we can create a nucleus in our lecture formats and in the discussions at the stands, in which the industry works together on a solution.”

Digital Hub and Digital Lab offer digitalisation at your fingertips

The topic of digitalization has finally claimed a top spot on the agenda of the process industry. The new exhibition group “Digital Hub” contributes to this: It is the central meeting point for digital experts and all participants interested in or actively involved in the digital transformation of the process industry. The exhibition area with a central stage puts digital showcases of the process industry in the spotlight and offers the latest insights from experts and solution providers and facilitates future-oriented discussions.

A total of six use cases for the connected and digitalized laboratory will be presented at the Digital Lab Action Area – the smart lab of tomorrow to experience, touch and try out. Equipment and software manufacturers will demonstrate cross-manufacturer digitalization solutions using relevant practical examples. The spectrum ranges from Cobot-assisted work processes for sample preparation and analysis, user-oriented process control with Laboratory Execution Systems, to horizontally and vertically connected yet modularly adaptable equipment solutions with the perspective of shared laboratory infrastructure and seamless integration between sample input and quality-assured analysis results. Innovative software and device solutions are supported by the Laboratory & Analytical Device Standard (LADS) for OPC UA.

„Digitalisation, sustainability, security of supply – the challenges ahead are enormous and can only be overcome together and across sectors”, says Thomas Scheuring. “Let us therefore use ACHEMA in August 2022 as the world’s only comprehensive showcase of the latest technology trends in our industry to find and tackle solutions together.”

Previous Post

GSK Unveils Its Transformation Through New Branding And Logo

Next Post

GARDP Helps Bugworks Assess New Antibiotics Effectiveness

Related Posts

Avadel Pharmaceuticals Receives
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025
Regulatory Trends in Pharma
Insights

Regulatory Trends in Pharma Manufacturing to Watch in 2025

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Next Post

GARDP Helps Bugworks Assess New Antibiotics Effectiveness

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In